Keywords: sanofi, taxotere, gets, priority, review, advanced, gastric

Sanofi's Taxotere gets priority review for advanced gastric cancer

Article | 12 December 2005

Print This

Sanofi-Aventis says that the US Food and Drug Administration has granted a six-month priority review for the supplemental New Drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in